IVD Quality Control Market Estimated to Reach $2.28 Billion by 2031
Meticulous Research®—a
leading market research company, published a research report titled, ‘IVD Quality Control
Market Size, Share, Forecast & Trends
Analysis by Offering (Product [Serum, Blood], Data Management, Service)
Technology (Biochemistry, Molecular, Immunoassay) Application (cardiology,
Oncology) End User – Global Forecast to 2031’
Download Free Sample Report@ https://www.meticulousresearch.com/download-sample-report/cp_id=3447?utm_source=blog&utm_medium=social&utm_campaign=product&utm_content=24-10-2024
Meticulous Research® projects the IVD quality control market to grow to $2.28 billion by 2031, with a CAGR of 4.3% from 2024 to 2031. This growth is primarily attributed to the rising prevalence of chronic conditions, an aging global population, and the increasing need for third-party quality controls and quality assessment reports. The expansion of clinical laboratories and the rising demand for Point-of-Care (POC) diagnostics further drive market growth. Despite these positive trends, stringent technical and regulatory requirements for quality controls continue to challenge the market's progress.
Opportunities for growth exist in the rising demand for multi-analyte and multi-instrument quality controls, although evolving regulatory frameworks and limited access to quality control materials remain barriers to growth.
Key players in the market include Siemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), and others. By 2024, immunoassay/immunochemistry technology will dominate the market, supported by its specificity, sensitivity, and cost advantages. The infectious diseases segment will also lead in application, driven by the ongoing need for diagnostics in combating diseases like HIV, dengue, and COVID-19.
In terms of end-users, hospitals and clinics are projected to hold the largest market share, driven by increasing hospital admissions and a higher volume of diagnostic tests. Asia-Pacific is expected to see the fastest growth rate due to the region's growing healthcare infrastructure and rising demand for early diagnostics.
About Meticulous
Research®:
Meticulous Research® was founded in 2010 and
incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private
limited company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market intelligence in North
America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services,
strengths, and values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention to details.
With the meticulous primary and secondary research techniques, we have built
strong capabilities in data collection, interpretation, and analysis of data
including qualitative and quantitative research with the finest team of
analysts. We design our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research, and
consulting solutions to address business challenges of sustainable growth.
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment